Kwality Pharmaceuticals Ltd
BSE:539997
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
|
Kwality Pharmaceuticals Ltd
BSE:539997
|
430B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
978.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.3B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
277.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.8B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
273B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
150.2B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
95.7B EUR |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
Kwality Pharmaceuticals Ltd
Glance View
Kwality Pharmaceuticals Pvt Ltd. engages in the manufacture of pharmaceutical formulations in dosage form. The company is headquartered in Amritsar, Punjab. The company went IPO on 2016-07-18. The firm operates through the segment of manufacturing a range of finished pharmaceutical formulations in a dosage form, such as tablets, liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations and oral rehydration solutions (ORS), among others. The company provides pharmaceutical formulations in various categories, such as beta-lactam and non-beta lactam, hormones and cytotoxic (oncology). The company manufactures beta-lactam and cephalosporin molecules in various dosage forms, such as tablets, capsules, dry powder for suspension and dry powder for injection. The company manufactures the anticancer products in various dosage forms, such as tablets, capsules and injectables. Its products are available in Europe, Africa and Asian countries, among others.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Kwality Pharmaceuticals Ltd is 17%, which is above its 3-year median of 14.2%.
Over the last 3 years, Kwality Pharmaceuticals Ltd’s Operating Margin has decreased from 33.4% to 17%. During this period, it reached a low of 7.6% on Dec 31, 2023 and a high of 33.4% on May 30, 2022.
